|
DK1248604T4
(da)
†
|
2000-01-21 |
2012-05-21 |
Novartis Ag |
Kombinationer indeholdende dipeptidylpeptidase-IV-inhibitorer og antidiabetiske midler
|
|
PT1572196E
(pt)
*
|
2002-12-10 |
2008-11-20 |
Novartis Ag |
Combinação de um inibidor da dpp-iv e um composto ppar alfa
|
|
DE10300099A1
(de)
*
|
2003-01-07 |
2004-07-15 |
Bayer Healthcare Ag |
Indol-Phenylsulfonamid-Derivate
|
|
DE10308351A1
(de)
*
|
2003-02-27 |
2004-11-25 |
Aventis Pharma Deutschland Gmbh |
1,3-substituierte Cycloalkylderivate mit sauren, meist heterocyclischen Gruppen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
|
US7652061B2
(en)
*
|
2003-05-20 |
2010-01-26 |
Novartis A.G. |
N-acyl nitrogen heterocycles as ligands of peroxisome proliferator-activated receptors
|
|
JP2009513523A
(ja)
*
|
2003-07-08 |
2009-04-02 |
ノバルティス アクチエンゲゼルシャフト |
ベンゼンスルホニルアミノ化合物およびそれらを含む医薬組成物
|
|
DE10335449A1
(de)
*
|
2003-08-02 |
2005-02-17 |
Bayer Healthcare Ag |
Bicyclische Indolinsulfonamid-Derivate
|
|
US20080125403A1
(en)
|
2004-04-02 |
2008-05-29 |
Merck & Co., Inc. |
Method of Treating Men with Metabolic and Anthropometric Disorders
|
|
FR2869904B1
(fr)
|
2004-05-07 |
2006-07-28 |
Fournier S A Sa Lab |
Modulateurs des recepteurs lxr
|
|
PE20060594A1
(es)
*
|
2004-09-09 |
2006-08-18 |
Novartis Ag |
Composicion farmaceutica que contiene un agonista de ppar
|
|
JP2008527008A
(ja)
*
|
2005-01-18 |
2008-07-24 |
ノバルティス アクチエンゲゼルシャフト |
二重ｐｐａｒアゴニスト化合物の使用法およびそのような化合物を含む薬剤送達デバイス
|
|
US7429667B2
(en)
|
2005-01-20 |
2008-09-30 |
Ardea Biosciences, Inc. |
Phenylamino isothiazole carboxamidines as MEK inhibitors
|
|
FR2886293B1
(fr)
*
|
2005-05-30 |
2007-08-24 |
Fournier S A Sa Lab |
Nouveaux composes de l'indoline
|
|
WO2006129164A1
(en)
|
2005-05-31 |
2006-12-07 |
Pfizer Japan Inc. |
Substituted aryloxy-n-bicyclomethyl acetamide compounds as vr1 antagonists
|
|
WO2007008541A2
(en)
*
|
2005-07-08 |
2007-01-18 |
Kalypsys, Inc. |
Cellular cholesterol absorption modifiers
|
|
GT200600302A
(es)
*
|
2005-07-13 |
2007-03-19 |
|
Agonistas de ppara/y y procesos de preparación
|
|
TW200804345A
(en)
|
2005-08-30 |
2008-01-16 |
Novartis Ag |
Substituted benzimidazoles and methods of preparation
|
|
CN101304993A
(zh)
*
|
2005-11-07 |
2008-11-12 |
Irm责任有限公司 |
作为ppar调节剂的化合物和组合物
|
|
GB0526257D0
(en)
*
|
2005-12-22 |
2006-02-01 |
Novartis Ag |
Organic compounds
|
|
EP2402317B1
(en)
|
2006-03-31 |
2013-07-03 |
Novartis AG |
DGAT inhibitor
|
|
MX2008013137A
(es)
|
2006-04-11 |
2008-10-21 |
Novartis Ag |
Compuestos organicos.
|
|
WO2007121269A2
(en)
|
2006-04-11 |
2007-10-25 |
Ardea Biosciences, Inc. |
N-aryl-n'alkyl sulfamides as mek inhibitors
|
|
ES2354182T3
(es)
|
2006-04-18 |
2011-03-10 |
Ardea Biosciences, Inc. |
Piridona sulfonamidas y piridona sulfamidas como inhibidores de mek.
|
|
PE20080888A1
(es)
|
2006-10-18 |
2008-08-26 |
Novartis Ag |
COMPUESTOS HETEROCICLICOS COMO INHIBIDORES DE LA ACIL-TRANSFERASA DE ACIL-CoA-DIACIL-GLICEROL 1 (DGAT1)
|
|
US8969514B2
(en)
|
2007-06-04 |
2015-03-03 |
Synergy Pharmaceuticals, Inc. |
Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
|
|
MX2009013293A
(es)
|
2007-06-04 |
2010-02-15 |
Synergy Pharmaceuticals Inc |
Agonistas de guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos.
|
|
CA2924418A1
(en)
|
2007-07-30 |
2009-02-05 |
Jean-Michel Vernier |
Derivatives of n-(arylamino) sulfonamides including polymorphs as inhibitors of mek as well as compositions, methods of use and methods for preparing the same
|
|
CA2697551C
(en)
|
2007-09-20 |
2013-03-12 |
Irm Llc |
Piperidine derivatives as modulators of gpr119 activity
|
|
US9305735B2
(en)
|
2007-09-28 |
2016-04-05 |
Brigham Young University |
Reinforced polymer x-ray window
|
|
US8498381B2
(en)
|
2010-10-07 |
2013-07-30 |
Moxtek, Inc. |
Polymer layer on X-ray window
|
|
US8736138B2
(en)
|
2007-09-28 |
2014-05-27 |
Brigham Young University |
Carbon nanotube MEMS assembly
|
|
EP2810951B1
(en)
|
2008-06-04 |
2017-03-15 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
|
|
EP2349484A2
(en)
|
2008-07-15 |
2011-08-03 |
Novartis AG |
Heteroaryl derivatives as dgat1 inhibitors
|
|
CA2730603C
(en)
|
2008-07-16 |
2019-09-24 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
|
|
US8247971B1
(en)
|
2009-03-19 |
2012-08-21 |
Moxtek, Inc. |
Resistively heated small planar filament
|
|
US8673919B2
(en)
|
2009-03-27 |
2014-03-18 |
Ardea Biosciences, Inc. |
Dihydropyridin sulfonamides and dihydropyridin sulfamides as MEK inhibitors
|
|
AU2010232923A1
(en)
*
|
2009-04-03 |
2011-11-03 |
Medisyn Technologies, Inc. |
Compositions for treatment of Alzheimer's disease
|
|
WO2011014520A2
(en)
|
2009-07-29 |
2011-02-03 |
Irm Llc |
Compounds and compositions as modulators of gpr119 activity
|
|
EA201200570A1
(ru)
|
2009-10-09 |
2012-11-30 |
Айрм Ллк |
Соединения и композиции в качестве модуляторов активности gpr119
|
|
EP2947073B1
(en)
*
|
2009-10-22 |
2019-04-03 |
Fibrotech Therapeutics Pty Ltd |
Fused ring analogues of anti-fibrotic agents
|
|
US8394858B2
(en)
|
2009-12-03 |
2013-03-12 |
Novartis Ag |
Cyclohexane derivatives and uses thereof
|
|
US7983394B2
(en)
|
2009-12-17 |
2011-07-19 |
Moxtek, Inc. |
Multiple wavelength X-ray source
|
|
US8697739B2
(en)
|
2010-07-29 |
2014-04-15 |
Novartis Ag |
Bicyclic acetyl-CoA carboxylase inhibitors and uses thereof
|
|
US20130156720A1
(en)
|
2010-08-27 |
2013-06-20 |
Ironwood Pharmaceuticals, Inc. |
Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
|
|
US9616097B2
(en)
|
2010-09-15 |
2017-04-11 |
Synergy Pharmaceuticals, Inc. |
Formulations of guanylate cyclase C agonists and methods of use
|
|
US8526574B2
(en)
|
2010-09-24 |
2013-09-03 |
Moxtek, Inc. |
Capacitor AC power coupling across high DC voltage differential
|
|
PE20140337A1
(es)
|
2010-10-07 |
2014-03-13 |
Novartis Ag |
Nuevas formas cristalinas de la sal sodica del acido (4-{4-[5-(6-trifluoro-metil-piridin-3-il-amino)-piridin-2-il]-fenil}-ciclhexil)-acetico
|
|
CA2824220C
(en)
|
2011-01-13 |
2020-09-01 |
Novartis Ag |
Novel heterocyclic derivatives and their use in the treatment of neurological disorders
|
|
EA201391033A1
(ru)
|
2011-01-13 |
2014-01-30 |
Новартис Аг |
Ингибиторы bace-2 для лечения метаболических расстройств
|
|
US8804910B1
(en)
|
2011-01-24 |
2014-08-12 |
Moxtek, Inc. |
Reduced power consumption X-ray source
|
|
US8750458B1
(en)
|
2011-02-17 |
2014-06-10 |
Moxtek, Inc. |
Cold electron number amplifier
|
|
US8929515B2
(en)
|
2011-02-23 |
2015-01-06 |
Moxtek, Inc. |
Multiple-size support for X-ray window
|
|
US8792619B2
(en)
|
2011-03-30 |
2014-07-29 |
Moxtek, Inc. |
X-ray tube with semiconductor coating
|
|
CN103619862A
(zh)
|
2011-04-14 |
2014-03-05 |
诺瓦提斯公司 |
糖苷衍生物及其用途
|
|
US8614195B2
(en)
|
2011-04-14 |
2013-12-24 |
Novartis Ag |
Glycoside derivatives and uses thereof
|
|
US9174412B2
(en)
|
2011-05-16 |
2015-11-03 |
Brigham Young University |
High strength carbon fiber composite wafers for microfabrication
|
|
US9076628B2
(en)
|
2011-05-16 |
2015-07-07 |
Brigham Young University |
Variable radius taper x-ray window support structure
|
|
US8989354B2
(en)
|
2011-05-16 |
2015-03-24 |
Brigham Young University |
Carbon composite support structure
|
|
CN103764635B
(zh)
|
2011-07-08 |
2016-01-20 |
诺华股份有限公司 |
新的三氟甲基-噁二唑衍生物及其在疾病治疗中的用途
|
|
UY34278A
(es)
|
2011-08-25 |
2013-04-05 |
Novartis Ag |
Derivados novedosos de oxazina y su uso en el tratamiento de enfermedades
|
|
US9187439B2
(en)
|
2011-09-21 |
2015-11-17 |
Inception Orion, Inc. |
Tricyclic compounds useful as neurogenic and neuroprotective agents
|
|
EA201490774A1
(ru)
|
2011-10-13 |
2014-08-29 |
Новартис Аг |
Новые производные оксазина и их применение при лечении заболевания
|
|
EP2785713B1
(en)
|
2011-11-28 |
2016-09-07 |
Novartis AG |
Novel trifluoromethyl-oxadiazole derivatives and their use in the treatment of disease
|
|
WO2013082106A1
(en)
|
2011-12-02 |
2013-06-06 |
The General Hospital Corporation |
Differentiation into brown adipocytes
|
|
US8761344B2
(en)
|
2011-12-29 |
2014-06-24 |
Moxtek, Inc. |
Small x-ray tube with electron beam control optics
|
|
WO2013163508A1
(en)
|
2012-04-27 |
2013-10-31 |
Novartis Ag |
Tetrahydropyran dgat1 inhibitors
|
|
MA37439B1
(fr)
|
2012-04-27 |
2017-02-28 |
Novartis Ag |
Inhibiteurs de dgat1 à ponts éthers cycliques pour le traitement de troubles medies par l'acyle coa-diacylglycerol transferase 1 (dgat1).
|
|
WO2014052619A1
(en)
|
2012-09-27 |
2014-04-03 |
Irm Llc |
Piperidine derivatives and compositions as modulators of gpr119 activity
|
|
CA2896861A1
(en)
|
2013-01-11 |
2014-07-17 |
Novartis Ag |
Meglumine salt forms of 2-((1r,4r)-4-(4-(5-(benzoxazol-2-ylamino)pyridin-2-yl)phenyl)cyclohexyl) acetic acid and their use as dgat1 inhibitors
|
|
US9173623B2
(en)
|
2013-04-19 |
2015-11-03 |
Samuel Soonho Lee |
X-ray tube and receiver inside mouth
|
|
EA201592263A1
(ru)
|
2013-06-05 |
2016-05-31 |
Синерджи Фармасьютикалз, Инк. |
Ультрачистые агонисты гуанилатциклазы c, способ их получения и использования
|
|
US10588980B2
(en)
|
2014-06-23 |
2020-03-17 |
Novartis Ag |
Fatty acids and their use in conjugation to biomolecules
|
|
US20170204149A1
(en)
|
2014-06-23 |
2017-07-20 |
Novartis Ag |
Hsa-gdf-15 fusion polypeptide and use thereof
|
|
CN108367053A
(zh)
|
2015-12-22 |
2018-08-03 |
诺华股份有限公司 |
使用生长分化因子15(gdf-15)治疗或改善代谢性疾病的方法
|
|
EP3437651A1
(en)
|
2017-08-03 |
2019-02-06 |
Université de Strasbourg |
Peptides for treatment and prevention of nonalcoholic fatty liver disease
|
|
RS67720B1
(sr)
|
2017-12-14 |
2026-02-27 |
Univ Strasbourg |
Peptidi za lečenje i prevenciju bolesti nealkoholne masne jetre
|
|
UY38485A
(es)
|
2018-11-27 |
2020-06-30 |
Novartis Ag |
Compuestos tetrámeros cíclicos como inhibidores de proproteína convertasa subtilisina/kexina tipo 9 (pcsk9), método de tratamiento, uso y su preparación
|
|
JP7657151B2
(ja)
|
2018-11-27 |
2025-04-04 |
ノバルティス アーゲー |
代謝性障害の処置のためのプロタンパク質コンバターゼスブチリシン／ケキシン９型（ｐｃｓｋ９）阻害剤としての環状ペプチド
|
|
CN113166101A
(zh)
|
2018-11-27 |
2021-07-23 |
诺华股份有限公司 |
作为治疗代谢障碍的蛋白质原转换酶枯草杆菌蛋白酶/kexin 9型（PCSK9）抑制剂的环状五聚体化合物
|
|
HUE062537T2
(hu)
|
2018-12-21 |
2023-11-28 |
Univ Strasbourg |
Peptidek diabetes és társult betegségek kezelésére
|
|
WO2022219495A1
(en)
|
2021-04-12 |
2022-10-20 |
Novartis Ag |
2-((4-((s)-2-(4-chloro-2-fluorophenyl)-2-methylbenzo[d][1,3]dioxol-4-yl)piperidin-1-yl)methyl)-1-(((s)-oxetan-2-yl)methyl)-1h-imidazole derivatives as activators of the glp1 receptor for the treatment of obesity
|
|
TW202333563A
(zh)
|
2021-11-12 |
2023-09-01 |
瑞士商諾華公司 |
用於治療疾病或障礙之二胺基環戊基吡啶衍生物
|
|
JP2025505198A
(ja)
|
2022-02-10 |
2025-02-21 |
ノバルティス アーゲー |
肥満の治療のためのｇｌｐ１受容体の活性化因子としての２－（（４－（（ｓ）－２－（４－クロロ－２－フルオロフェニル）－２－メチルベンゾ［ｄ］［１，３］ジオキソール－４－イル）ピペリジン－１－イル）メチル）－１－（（（ｓ）－オキセタン－２－イル）メチル）－１ｈ－イミダゾール誘導体
|